REVIEW
|
doi:10.20944/preprints202311.1826.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Breast cancer; Estrogen receptor-positive; endocrine therapies; resistance; selective estrogen degrades; Oral
Online: 29 November 2023 (08:15:18 CET)